Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
Kathy Giusti | Photograph courtesy of the Multiple Myeloma Research Foundation
You might also like
Harvard Graduate Student Union Authorizes Another Strike
The University warns this walkout may not be protected by labor law, an assertion the union disputes.
FAS Readies for Administrative Transition
Faculty leaders say layoffs will yield $20 million in annual savings.
Trump Administration Asks Appeals Court to Restore Harvard Funding Cuts
The government’s lawyers homed in on a jurisdictional argument for its authority to to terminate federal grants.
Most popular
Explore More From Current Issue
Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.
Tell us about how social media impacts your daily life.
From competing in youth gymnastics to studying tetrapods, the Harvard curator has always chased her curiosity.